Women’s reproductive cancers—primarily including Ovarian, Endometrial, and Uterine cancers—refer to malignancies that originate within the female reproductive system. While each type is unique, they all require specialized diagnostic and treatment approaches.
At Medical Survey, we believe that understanding these conditions is the first step toward prevention and recovery. We prioritize early detection and personalized treatment plans to ensure every woman receives the expert, empathetic care she deserves.
Gynecologic cancers encompass any cancer that begins in a woman's reproductive organs. At Medical Survey, we focus on providing a clear understanding and a targeted path forward for the three most common types:
While these symptoms can be caused by non-cancerous conditions, they are your body’s way of asking for attention. At Medical Survey, we provide the diagnostic clarity you need to move forward with confidence. Here are a few common symptoms;
Ongoing discomfort, pressure, or cramping in the lower abdomen or pelvic area that does not go away with standard cycles.
A feeling of fullness or visible swelling in the abdomen that persists for
more than two weeks, often associated with ovarian cancer.
A noticeable change in appetite where you feel
"stuffed" after eating only a small amount of food.
Persistent constipation, diarrhea, or gas that represents a significant
change from your normal digestive patterns.
Understanding your risk profile is a key part of proactive health management. At Medical Survey, we look at these primary factors to help assess your health and create personalized screening schedules:
The risk for most gynecologic cancers, particularly ovarian and endometrial, increases as you get older. Most cases are diagnosed in women over the age of 50 or those who have already transitioned through menopause.
High levels of estrogen without a balance of progesterone (often called "unopposed estrogen") can cause the uterine lining to overgrow. This can be caused by certain hormone replacement therapies or medical conditions like PCOS.
Excess body fat can change other hormones into estrogen, increasing the lifetime exposure of the uterus to this hormone.
Women who have never been pregnant or those who started their menstrual periods at a very early age (before 12) or entered menopause late (after 55) may have a slightly higher risk due to more lifetime ovulatory cycles.
Previous health conditions, such as Endometrial Hyperplasia (a thickening of the uterine lining) or a prior diagnosis of breast or colon cancer, can elevate the likelihood of developing a reproductive cancer.
A family history of breast, ovarian, or colon cancer can be a significant indicator. Specific inherited gene mutations, such as BRCA1 and BRCA2 or those associated with Lynch Syndrome, can substantially increase your risk.
The terms are often used interchangeably, but there is a slight difference. Endometrial cancer
starts specifically in the lining of the uterus (the endometrium) and is the most common type.
Uterine cancer is a broader category that also includes uterine sarcomas, which start in the
muscle or connective tissue.
Not necessarily. While a family history—specifically of breast, ovarian, or colon cancer—can
increase your risk, it is only one piece of the puzzle. At Medical Survey, we offer genetic
counseling and testing to help you understand your specific risk and create a proactive
monitoring plan.
While risk increases with age (especially post-menopause), these cancers can affect women at
any stage of life. We recommend that all women have an annual gynecological exam starting in
early adulthood to establish a health baseline.
Unlike cervical cancer, which is detected via a Pap smear, there is no single routine screening
test for ovarian cancer for women without symptoms. However, if you are at high risk or
experiencing symptoms, our specialists use a combination of pelvic exams, transvaginal
ultrasounds, and CA-125 blood tests for evaluation.
The HPV vaccine is highly effective at preventing cervical, vaginal, and vulvar cancers caused by
the Human Papillomavirus. However, it does not prevent ovarian or endometrial cancers. It
remains a crucial tool in your overall preventative health strategy.
Treatment is highly personalized. Depending on your diagnosis, it may involve minimally
invasive surgery, radiation therapy, chemotherapy, or targeted biological therapies. We focus on
the most effective, least invasive options possible to support your recovery.